India Globalization Capital, Inc. (NYSEMKT:IGC) is engaged in the development of cannabis-based therapies to treat pain, PTSD, seizures, cachexia, chronic and terminal neurological and oncological diagnoses, and other life altering conditions. In support of this mission, IGC has assembled a portfolio of patent filings for its phytocannabinoid-based treatments. The company is based in Bethesda, Maryland.
![](/images/buts/twitter-social.png)
![](/images/buts/facebook-social.png)
![](/images/buts/linkedin-social.png)
![](/images/buts/heroes_alert_button.jpg)